Alkem Laboratories Declines 4.21%: 5 Key Factors Driving the Weekly Downturn

21 September: Upgrade to Hold Sparks Initial Optimism

On Monday, 21 September 2026, Alkem Laboratories’ stock gained 3.03% to close at Rs.5,501.60 following an upgrade from Sell to Hold by MarketsMOJO. This upgrade was driven by improved technical indicators such as bullish Bollinger Bands on weekly and monthly charts and a mildly bullish On-Balance Volume (OBV) monthly trend, despite mixed signals from MACD and moving averages. The stock traded near its 52-week high of Rs.5,933.00, signalling tentative investor optimism. However, the Relative Strength Index (RSI) remained neutral, indicating no clear momentum direction. The Sensex closed higher by 0.46% that day, underscoring Alkem’s relative strength.

22 September: Technical Momentum Turns Bearish Amid Price Decline

On 22 September, the stock reversed course, declining 2.76% to Rs.5,350.00, underperforming the Sensex which fell 0.32%. Technical momentum shifted from mildly bearish to outright bearish, with the MACD on the weekly chart confirming sustained downward pressure. Daily moving averages turned firmly bearish, and Bollinger Bands on the weekly timeframe also signalled downside risk. Despite the decline, the stock’s long-term performance remained robust, with a 10-year return of 215.87% versus the Sensex’s 162.59%. This day marked the beginning of a more cautious market stance on Alkem.

24 September: Surge in Open Interest Amid Mixed Technical Signals

On 24 September, Alkem Laboratories saw a sharp 16.4% increase in open interest in its derivatives segment, rising from 19,974 to 23,242 contracts. This surge occurred despite the stock closing lower at Rs.5,330.00, down 1.55% for the day and trading near its 52-week low of Rs.5,052.05. The derivatives turnover was substantial, with futures valued at approximately ₹41,862 lakhs and options at ₹20,741.79 crores. The stock’s price remained above its 20-day moving average but below longer-term averages, reflecting a mixed technical outlook. Delivery volumes declined by 23.59%, indicating waning investor participation in the cash market. The increase in open interest alongside falling prices suggests fresh short positions or hedging activity amid sector uncertainties.

24 September: Mojo Grade Downgraded to Sell as Technicals Weaken

Later on 24 September, MarketsMOJO downgraded Alkem Laboratories from Hold to Sell, citing deteriorating technical indicators and flat financial performance. The downgrade reflected a shift from mildly bearish to outright bearish technical grades, with the MACD bearish on weekly charts and Bollinger Bands signalling downside risk. The company’s Q1 FY26-27 results showed a 20.4% decline in profit after tax to ₹519.95 crores and rising interest expenses by 30.32%, pressuring margins. Promoter shareholding also declined by 1.5% to 49.7%, raising concerns about confidence in near-term prospects. The stock closed the day at Rs.5,330.00, trading closer to its 52-week low and underperforming the sector and Sensex.

25 September: Continued Open Interest Growth Amid Price Consolidation

On the final trading day of the week, 25 September, open interest surged further by 18.7% to 24,991 contracts, with futures volume at 14,651 contracts and a total derivatives value of ₹47,607.62 lakhs. Despite this, the stock declined 1.13% to close at Rs.5,269.95, hovering just 4.06% above its 52-week low. Delivery volumes fell sharply by 59.19%, signalling reduced conviction among long-term holders. The stock remained above its 20-day moving average but below other key moving averages, indicating short-term weakness amid longer-term bearish trends. The Mojo Score dropped to 44.0, confirming the Sell rating. This combination of rising derivatives activity and price consolidation suggests active repositioning by traders amid uncertainty.

Key Takeaways

Positive Signals: Early-week technical improvements and a Mojo Grade upgrade to Hold reflected tentative optimism. The stock’s long-term returns remain strong, outperforming the Sensex over 3, 5, and 10 years. Monthly technical indicators such as Bollinger Bands and OBV showed signs of accumulation, suggesting some underlying investor interest.

Cautionary Signals: The stock declined 4.21% over the week, underperforming the Sensex’s 0.76% fall. Technical momentum deteriorated midweek, with bearish MACD, moving averages, and Bollinger Bands dominating daily and weekly charts. The downgrade back to Sell on 24 September highlighted concerns over flat financial performance, rising interest expenses, and reduced promoter confidence. Sharp surges in derivatives open interest amid falling prices suggest speculative short positioning or hedging, adding to volatility risks. Declining delivery volumes indicate waning conviction among long-term holders.

Conclusion

Alkem Laboratories Ltd’s week was marked by a shift from cautious optimism to growing technical weakness and investor caution. Despite a strong long-term track record and initial upgrade to Hold, deteriorating financial trends and bearish technical signals culminated in a downgrade to Sell. The stock’s proximity to its 52-week low and rising derivatives activity underscore a consolidation phase with heightened volatility potential. Investors should monitor key technical levels and sector developments closely, as the stock navigates a challenging near-term outlook amid mixed market signals.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today